CLINICAL_TRIALS
trial_result
· 2020-09-04
Clinical Trial Update: A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100) [Phase 1]
Summary
Phase 1 trial update of avelumab plus axitinib in advanced hepatocellular carcinoma; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Carcinoma, Hepatocellular | Phase 1 | Status: COMPLETED | Results posted: 2020-09-04